Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. VGHCX: which is better?

Bottom line

GNMX vs VGHCX: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and VGHCX (Vanguard Health Care Fund) are both etfs.

Updated Nov 19, 2026

GNMX vs VGHCX side by side

GNMXVGHCX
TypeETFMutual fund
Fund familyCorgi Genomics & Precision MedicineVanguard
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.33%
Annual cost per $10k—$33
10-yr cost on $10k (prospectus)—$418
Max front loadNone0%
12b-1 fee—0%
1-yr return—+17.3%
5-yr return (annualized)—+6.6%
10-yr return (annualized)—+7.7%
Best quarter—+16.8%
Worst quarter—−12.3%
Net assets (fund)—$38.2B
Number of holdings—97
Portfolio turnover—47%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and VGHCX share none of their top holdings.

GNMX top 10

    VGHCX top 10

    1. Eli Lilly & Co — 8.61%
    2. Merck & Co Inc — 5.44%
    3. Johnson & Johnson — 4.83%
    4. AstraZeneca PLC — 4.59%
    5. UnitedHealth Group Inc — 4.05%
    6. Gsk Plc — 3.00%
    7. Edwards Lifesciences Corp — 2.56%
    8. Intuitive Surgical Inc — 2.52%
    9. CVS Health Corp — 2.52%
    10. Cencora Inc — 2.47%

    FAQ

    What is the difference between GNMX and VGHCX?
    GNMX (Corgi Genomics & Precision Medicine ETF) and VGHCX (Vanguard Health Care Fund) are both etfs.
    Should I own both GNMX and VGHCX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.